| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 13,070 | 32,925 | 22,263 | | Cost of Revenue | 7,872 | 18,911 | 16,736 | | | Gross Profit | 5,198 | 14,014 | 5,527 | | | Operating Expenses | | Research Development | 5,210 | 3,705 | 4,646 | | Selling General and Administrative | 7,930 | 8,714 | 14,256 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,942) | 1,595 | (13,375) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 40 | 17,013 | 162 | | Earnings Before Interest And Taxes | (7,902) | 18,608 | (13,213) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (7,902) | 18,608 | (13,213) | | Income Tax Expense |
-
| 504 |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,902) | 18,104 | (13,213) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,902) | 18,104 | (13,213) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,902) | $18,104 | ($13,213) |
|
0.22% Nasdaq 
Income Statement
